Study Drug Delays Type 1 Diabetes in High Risk Children and Adults

photo

A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine. Dr. Bill Russell is the PI of the TrialNet project. 

Read more >>


Academic Pediatric Association honors Barkin

Barkin photo

Shari Barkin, MD, MSHS, division chief of General Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, was honored recently with the 2019 Academic Pediatric Association (APA) Research Award.

Read more >>


Diabetes study reveals decline in pancreas volume for some

Investigators using MRI technology to study changes in pancreatic volume to better understand the progression of Type 1 diabetes include, from left, Melissa Hilmes, MD, Daniel Moore, MD, PhD, Alvin Powers, MD, Jon Williams, PhD, and Jack Virostko, PhD.

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) have discovered a progressive decline in pancreas volume over a one-year period in children and adolescents with newly diagnosed Type 1 diabetes.

Read more >>


Vanderbilt scientists report new modeling of brain signaling

hamm

Heidi Hamm, Ph.D. and colleagues have generated a new mouse model with defects in SNAP25, a SNARE protein,which decreased the inhibition of neurotransmitter exocytosis and led to physiological and behavioral phenotypes.

Read more >>


Sheila Collins, Ph.D. has been featured as one of Diabetes Forecast magazine's "5 Women Make Waves in Diabetes Research."

Collins

Dr. Collins' research on brown fat cells and white fat cells may lead to the development of treatments to combat type 2 diabetes and associated cardiovascular disease.

Read more >>


Bile acids mediate metabolic benefits of weight-loss surgery

Abumrad-Albaugh-Flynn-JR007_edited-1.jpg

A team of Vanderbilt investigators has pinpointed the role of bile acids and a specific signaling pathway in the positive metabolic effects of weight-loss surgery.

Read more >>


A collaboration of Basic Sciences labs has recently identified the earliest detectable marker of pancreatic progenitors.

Lau_Gu-Image-297x300.jpg

Vanderbilt Basic Sciences investigators Guoqiang Gu, Ken Lau, Emily Hodges, and David Jacobson, along with their collaborators and laboratories began to examine the role of the Myt1 transcription factor in PPC differentiation.

Read more >>


Dr. Ray Blind named to editorial position

Blind.png

Congratulations to Ray Blind, who has just been named Jr. Associate Editor for the Journal of Lipid Research for 2019-2021.


New core to support investigations into metabolic disorders

Metabolic-Core-group_edited-1.jpg

John Koethe, MD, MSCI, left, Kevin Niswender, MD, PhD, LaToya Hannah, MSN, APRN, Matt Luther, MD, associate professor of Medicine, and colleagues have formed a new Human Metabolic Physiology Core at VUMC to support studies requiring human adipose tissue.

Read more >>


Study points to alternate therapy for rare form of diabetes

Diabetes-group-SU-48_edited-1.jpg

Raymond Blind, PhD, left, Xin Tong, PhD, Rachana Haliyur, PhD, and Marcela Brissova, PhD, are part of a research team that discovered new information about the cellular dysfunction that occurs with a rare form of diabetes. (photo by Susan Urmy)

Read more >>


Al Powers, MD among five Vanderbilt faculty elected AAAS fellows

AAAS_logo.jpg

Five Vanderbilt University faculty members selected by their peers for membership in the world’s largest general scientific society “because of their scientifically or socially distinguished efforts to advance science or its applications.”

Read more >>